Neue Entwicklungen in der Behandlung des Basalzellkarzinoms
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG(2023)
Abstract
In 2013, systemic therapy has been introduced in the treatment of local advanced (laBCC) and metastatic basal cell carcinoma (mBCC). Meanwhile, immunotherapy has been approved in this indication as well. Additional immunotherapies and other classes of drugs including combination regimens are currently being inves-tigated in clinical trials. These agents might considerably expand the therapeutic armamentarium for laBCC and mBCC in the future.
MoreTranslated text
Key words
der behandlung des basalzellkarzinoms
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined